Zacks Small-Cap Research

Zacks Investment Research Page 2 scr.zacks.com INITIATING COVERAGE We are initiating coverage of Dyadic International Inc. (OTCQX: DYAI) with a $4.50 price target based on our estimates for commercialization of the companys proprietary C1 technology. C1 is a gene expression platform ................
................